University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 22 of 23
Nutritional Supplement, Eccentric Exercise and Recovery
NCT01444170
CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
NCT00365833
Intermittent Cold and Dry Air Underneath Football Shoulder Pads
NCT00349804
Pharyngocise Dose Response Study
NCT01279837
Skeletal Muscle Apoptosis and Physical Performance; Oxidative RNA/DNA Damage and Repair in Aged Human Muscle
NCT01644279
Desensitization of Renal Transplant Candidates
NCT00298883
Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer
NCT00294203
Effectiveness of Adding Behavioral Therapy to Physical Therapy to Treat Low Back Pain
NCT00373867
Stereotactic Body Radiation Therapy (SBRT) for Lung Tumors
NCT00632281
Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption
NCT00235573
Pharmacogenomic Evaluation of Antihypertensive Responses
NCT00246519
Stereotactic Body Radiation Therapy (SBRT) for Tumors Near the Spinal Cord
NCT00631670
The Impact of Dosimeter on Measurement of Airway Responsiveness to Methacholine
NCT00145990
Sensible Treatment of Obesity in Rural Youth . . .
NCT00248677
Uric Acid and Hypertension in African Americans
NCT00241839
MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression
NCT00187941
Mood and Subthalamic Nucleus (STN) Deep Brain Stimulation
NCT00954772
Biopsychosocial Factors' Influence on Shoulder Pain
NCT00187863
Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm Gestation
NCT00325026
Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)
NCT00130481
Umbilical Cord Blood Infusion to Treat Type 1 Diabetes
NCT00305344
Randomized Trial Comparing Misoprostol and Foley Bulb for Pregnancy Termination in the Second Trimester
NCT00324519
Neurological Influences on Drug Prevention Intervention
NCT00198939
Youth Drug Abuse Family and Cognitive-Behavioral Therapy
NCT00198874
The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma
NCT00133042
Masked Faces in Parkinson Disease: Mechanism and Treatment
NCT00350402
Short Versus Long Wire ERCP Systems
NCT00867204
A Study of a Potential Mechanisms of Spinal Manipulation in the Treatment of Low Back Pain
NCT00922220
Atrial and Brain Natriuretic Peptides in Bronchiolitis
NCT00347880
EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia
NCT00187889
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
NCT00361283
Evaluation of Biocleanse Allografts For ACL Reconstruction
NCT00187876
Expiratory Muscle Training in Patients With Parkinson's Disease
NCT00843739
Effects of Deep Brain Stimulation on Motor, Mood, and Cognitive Symptoms in Parkinson's Disease
NCT00360009
Aripiprazole in the Treatment of Tourette's Syndrome
NCT00282139
Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer
NCT00596895
Brain Imaging and Pain in Irritable Bowel Syndrome
NCT00065754
Pilot Trial for Implementation of a MPA PK Monitoring Strategy
NCT00187915
WISE ARIC: Retinal Photography in Women With Chest Pain
NCT00187954
Mindfulness-Based Stress Reduction and Myocardial Ischemia
NCT00224835
Impact of Anti-static Chamber/Mask
NCT00307970
Effect of Age and Device on Delivery of Fluticasone
NCT00308932
Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder
NCT00187928
Effect of Celecoxib on Markers of Vascular Inflammation
NCT00471341
Muscle Composition and Function for Swallowing in Head/Neck Cancer Patients
NCT00796952
4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?
NCT00067756
Prevention of Dichloroacetate Toxicity
NCT00031161
Outcome Study of Complex Distal Radius Fractures
NCT00160810
Deep Brain Stimulation for Treatment-Resistant Obsessive Compulsive Disorder
NCT00057603
QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial Ischemia
NCT00150826
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.